<ul>
<li>Torrent Pharma share price surged over 8% to touch a 52-week high on Monday after the company's Q4 results were mostly in line with the Street's estimates.</li>
<li>The company reported a 56.45% rise in its consolidated net profit to ₹449 crore for the March quarter.</li>
<li>"We are seeing strong volumes in this move and expect the uptrend to continue," said Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One.</li>
</ul>
<p><strong>Torrent Pharma's share price hits a 52-week high post robust Q4 results, with analysts predicting further growth.</strong></p>
<h2><strong>Torrent Pharma's Q4 Performance: Key Highlights</strong></h2>
<p>Torrent Pharmaceuticals reported a consolidated revenue from operations of ₹2,745 crore for the fourth quarter of FY24, up from ₹2,491 crore in the same period the previous year. The company's revenue in India increased by 10% to ₹1,380 crore, while revenue in Brazil grew by 17% to ₹372 crore and in Germany by 11% to ₹280 crore. However, US business revenue was down 6% to ₹262 crore.</p>
<h3><strong>Analysts' Take on Torrent Pharma's Performance</strong></h3>
<p>According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, the stock prices have seen a strong gap-up opening above the previous session high. "We are seeing strong volumes in this move and expect the uptrend to continue. Recently, ₹2,750 has been acting as a hurdle, and a break beyond this would trigger a trending move, possibly towards ₹2,900, and ₹2,650 is seen as support," he added.</p>
<h3><strong>Conclusion</strong></h3>
<p>Torrent Pharma's robust Q4 performance has led to a significant surge in its share price, reaching a 52-week high. With strong revenue growth in key markets like India, Brazil, and Germany, and positive analyst sentiments, the outlook for Torrent Pharma appears promising. Investors are advised to monitor the stock closely for potential investment opportunities.</p>
Torrent Pharma (TORN) Soars 8% After Strong Q4 Results: Is Now the Ideal Investment Opportunity?
(04:05 PM UTC)
2 min read
Contents
591 views
0 commentsGideon Wolf
GideonWolff is a 27-year-old technical analyst and journalist with extensive experience in the cryptocurrency industry. With a focus on technical analysis and news reporting, GideonWolff provides valuable insights on market trends and potential opportunities for both investors and those interested in the world of cryptocurrency.
View all postsComments
Yorumlar
Other Articles
Salesforce (CRM) Shares Plunge 20% on Weak Earnings Forecast, Impacting US Stock Markets
May 30, 2024 at 11:17 PM UTC
EU Wheat Crop Forecast for 2024/25 Hits 4-Year Low, Stockpiles Expected to Rise
May 30, 2024 at 10:48 PM UTC
2024 IPO Surge: 57% of SME Issues Achieve Over 100% Subscription Rate
May 30, 2024 at 09:52 PM UTC